A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients

BackgroundHepatocellular carcinoma (HCC) is one of the malignant tumors with high morbidity and mortality worldwide. Immunotherapy has emerged as an increasingly important cancer treatment modality. However, the potential relationship between immune genes and HCC still needs to be explored. The purp...

Full description

Bibliographic Details
Main Authors: Dingde Ye, Yaping Liu, Guoqiang Li, Beicheng Sun, Jin Peng, Qingxiang Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.766072/full
_version_ 1818398869666398208
author Dingde Ye
Yaping Liu
Guoqiang Li
Beicheng Sun
Jin Peng
Qingxiang Xu
Qingxiang Xu
author_facet Dingde Ye
Yaping Liu
Guoqiang Li
Beicheng Sun
Jin Peng
Qingxiang Xu
Qingxiang Xu
author_sort Dingde Ye
collection DOAJ
description BackgroundHepatocellular carcinoma (HCC) is one of the malignant tumors with high morbidity and mortality worldwide. Immunotherapy has emerged as an increasingly important cancer treatment modality. However, the potential relationship between immune genes and HCC still needs to be explored. The purpose of this study is to construct a new prognostic risk signature to predict the prognosis of HCC patients based on the expression of immune-related genes (IRGs) and explore its potential mechanism.MethodsWe analyzed the gene expression data of 332 HCC patient samples and 46 adjacent normal tissues samples (Solid Tissue Normal including cirrhotic tissue) in The Cancer Genome Atlas (TCGA) database and clinical characteristics. We analyzed the gene expression data, identified differentially expressed IRGs in HCC tissues, filtered IRGs with prognostic value to construct an IRG signature, and classified patients into high and low gene expression groups based on the expression of IRGs in their tumor tissues. We also investigated the potential molecular mechanisms of IRGs through a bioinformatics approach using Protein-Protein Interaction (PPI) network, Kyoto Encyclopedia of Genes and Genomes (KEGG) database analysis and Gene Ontology (GO) database analysis. Differentially expressed IRGs associated with significant clinical outcomes (SIRGs) were identified by univariate Cox regression analysis. An immune-related risk score model (IRRSM) was established based on Lasso Cox regression analysis and multivariate Cox regression analysis. Based on the IRRSM, the immune score of the patients was calculated, and the patients were divided into high-risk and low-risk patients according to the median score, and the differences in survival between the two groups were compared. Then, the correlation analysis between the IRRSM and clinical characteristics was performed, and the IRRSM was validated using the International Cancer Genome Consortium (ICGC) database.ResultsThe IRRSM was eventually constructed and confirmed to be an independent prognostic model for HCC patients. The IRRSM was shown to be positively correlated with the infiltration of four types of immune cells.ConclusionOur results showed that some SIRGs have potential value for predicting the prognosis and clinical outcomes of HCC patients. IRGs affect the prognosis of HCC patients by regulating the tumor immune microenvironment (TIME). This study provides a new insight for immune research and treatment strategies in HCC patients.
first_indexed 2024-12-14T07:11:38Z
format Article
id doaj.art-4dd0b97f82c843bd826d21a8701e6fa6
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-14T07:11:38Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-4dd0b97f82c843bd826d21a8701e6fa62022-12-21T23:11:49ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-11-011110.3389/fonc.2021.766072766072A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the PatientsDingde Ye0Yaping Liu1Guoqiang Li2Beicheng Sun3Jin Peng4Qingxiang Xu5Qingxiang Xu6Nanjing Drum Tower Hospital, Medicine School of Southeast University, Nanjing, ChinaSchool of Life Science and Technology, Southeast University, Nanjing, ChinaDepartment of General Surgery, Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, ChinaDepartment of General Surgery, Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, ChinaDepartment of General Surgery, Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, ChinaNanjing Drum Tower Hospital, Medicine School of Southeast University, Nanjing, ChinaDepartment of General Surgery, Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, ChinaBackgroundHepatocellular carcinoma (HCC) is one of the malignant tumors with high morbidity and mortality worldwide. Immunotherapy has emerged as an increasingly important cancer treatment modality. However, the potential relationship between immune genes and HCC still needs to be explored. The purpose of this study is to construct a new prognostic risk signature to predict the prognosis of HCC patients based on the expression of immune-related genes (IRGs) and explore its potential mechanism.MethodsWe analyzed the gene expression data of 332 HCC patient samples and 46 adjacent normal tissues samples (Solid Tissue Normal including cirrhotic tissue) in The Cancer Genome Atlas (TCGA) database and clinical characteristics. We analyzed the gene expression data, identified differentially expressed IRGs in HCC tissues, filtered IRGs with prognostic value to construct an IRG signature, and classified patients into high and low gene expression groups based on the expression of IRGs in their tumor tissues. We also investigated the potential molecular mechanisms of IRGs through a bioinformatics approach using Protein-Protein Interaction (PPI) network, Kyoto Encyclopedia of Genes and Genomes (KEGG) database analysis and Gene Ontology (GO) database analysis. Differentially expressed IRGs associated with significant clinical outcomes (SIRGs) were identified by univariate Cox regression analysis. An immune-related risk score model (IRRSM) was established based on Lasso Cox regression analysis and multivariate Cox regression analysis. Based on the IRRSM, the immune score of the patients was calculated, and the patients were divided into high-risk and low-risk patients according to the median score, and the differences in survival between the two groups were compared. Then, the correlation analysis between the IRRSM and clinical characteristics was performed, and the IRRSM was validated using the International Cancer Genome Consortium (ICGC) database.ResultsThe IRRSM was eventually constructed and confirmed to be an independent prognostic model for HCC patients. The IRRSM was shown to be positively correlated with the infiltration of four types of immune cells.ConclusionOur results showed that some SIRGs have potential value for predicting the prognosis and clinical outcomes of HCC patients. IRGs affect the prognosis of HCC patients by regulating the tumor immune microenvironment (TIME). This study provides a new insight for immune research and treatment strategies in HCC patients.https://www.frontiersin.org/articles/10.3389/fonc.2021.766072/fullhepatocellular carcinomaimmune-related genesimmune-related risk scoreprognosisnomogram
spellingShingle Dingde Ye
Yaping Liu
Guoqiang Li
Beicheng Sun
Jin Peng
Qingxiang Xu
Qingxiang Xu
A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
Frontiers in Oncology
hepatocellular carcinoma
immune-related genes
immune-related risk score
prognosis
nomogram
title A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
title_full A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
title_fullStr A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
title_full_unstemmed A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
title_short A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
title_sort new risk score based on eight hepatocellular carcinoma immune gene expression can predict the prognosis of the patients
topic hepatocellular carcinoma
immune-related genes
immune-related risk score
prognosis
nomogram
url https://www.frontiersin.org/articles/10.3389/fonc.2021.766072/full
work_keys_str_mv AT dingdeye anewriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT yapingliu anewriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT guoqiangli anewriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT beichengsun anewriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT jinpeng anewriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT qingxiangxu anewriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT qingxiangxu anewriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT dingdeye newriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT yapingliu newriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT guoqiangli newriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT beichengsun newriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT jinpeng newriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT qingxiangxu newriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients
AT qingxiangxu newriskscorebasedoneighthepatocellularcarcinomaimmunegeneexpressioncanpredicttheprognosisofthepatients